<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nutr J</journal-id>
      <journal-title>Nutrition Journal</journal-title>
      <issn pub-type="epub">1475-2891</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">14627440</article-id>
      <article-id pub-id-type="pmc">293472</article-id>
      <article-id pub-id-type="publisher-id">1475-2891-2-15</article-id>
      <article-id pub-id-type="doi">10.1186/1475-2891-2-15</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Effects of isoflavones (soy phyto-estrogens) on serum lipids: a meta-analysis of randomized controlled trials</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Yeung</surname>
            <given-names>John</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>john@epidemiology.org.hk</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>Tak-fu</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>yutakfu1@yahoo.com.hk</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Medical Centre, Kowloon Motor Bus Company, Hong Kong</aff>
      <aff id="I2"><label>2</label>Medical Centre, G/F, Greenrich Mansion, 100 Castle Peak, Hong Kong</aff>
      <pub-date pub-type="collection">
        <year>2003</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>11</month>
        <year>2003</year>
      </pub-date>
      <volume>2</volume>
      <fpage>15</fpage>
      <lpage>15</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.nutritionj.com/content/2/1/15"/>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>9</month>
          <year>2003</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>11</month>
          <year>2003</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2003 Yeung and Yu; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2003</copyright-year>
        <copyright-holder>Yeung and Yu; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Objectives</title>
          <p>To determine the effects of isoflavones (soy phyto-estrogens) on serum total cholesterol (TC), low density lipoprotein cholesterol (LDL), high density lipoprotein cholesterol (HDL) and triglyceride (TG).</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>We searched electronic databases and included randomized trials with isoflavones interventions in the forms of tablets, isolated soy protein or soy diets. Review Manager 4.2 was used to calculate the pooled risk differences with fixed effects model.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Seventeen studies (21 comparisons) with 853 subjects were included in this meta-analysis. Isoflavones tablets had insignificant effects on serum TC, 0.01 mmol/L (95% CI: -0.17 to 0.18, heterogeneity p = 1.0); LDL, 0.00 mmol/L (95% CI: -0.14 to 0.15, heterogeneity p = 0.9); HDL, 0.01 mmol/L (95% CI: -0.05 to 0.06, heterogeneity p = 1.0); and triglyceride, 0.03 mmol/L (95% CI: -0.06 to 0.12, heterogeneity p = 0.9). Isoflavones interventions in the forms of isolated soy protein (ISP), soy diets or soy protein capsule were heterogeneous to combine.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Isoflavones tablets, isolated or mixtures with up to 150 mg per day, seemed to have no overall statistical and clinical benefits on serum lipids. Isoflavones interventions in the forms of soy proteins may need further investigations to resolve whether synergistic effects are necessary with other soy components.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>meta-analysis</kwd>
        <kwd>isoflavones</kwd>
        <kwd>soy</kwd>
        <kwd>phytoestrogens</kwd>
        <kwd>lipids</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>In recent years, phytoestrogens have attracted a great deal of interests in the medical and scientific literature. It also appears in the lay press for its effects on cardiovascular and menopausal health, and even cancer prevention. These compounds are present in large quantities in soybeans, clover and some legumes. Because of resemblances to human estrogen and the observations that Asian populations who consume more isoflavones compared with women in western countries have less menopausal symptoms, isoflavones are postulated as natural products that may be beneficial to postmenopausal women in cardiovascular health. Commercial products containing different quantities and mixtures of isoflavones are now widely available. A meta-analysis of soy protein in 1995 found significant cholesterols lowering effects when compared with animal proteins [<xref ref-type="bibr" rid="B1">1</xref>]. The authors suggest that isoflavones may be the principal physiologically active components responsible for the lipid lowering effects. However, it is still controversial [<xref ref-type="bibr" rid="B5">5</xref>]. Many reviews and editorials [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>] have discussed the relevance of phytoestrogens on cardiovascular health and hypocholesterolemic effects but there was no meta-analysis up to our searching.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Searching strategy</title>
        <p>We searched the databases from ACP Journal Club 1991 to Oct 2002, Cochrane Controlled Trials Register 3rd Quarter 2002, Cochrane Database of Systematic Reviews 4th Quarter 2002, Database of Abstracts of Reviews of Effectiveness 4th Quarter 2002, British Nursing Index (BNI) 1994 to Oct 2002, CANCERLIT 1975 to Oct 2002, CINAHL 1982 to Oct Week 4 2002, CSA &#x2013; Life Sciences Collection 1982 to Oct 2002, EMBASE 1980 to 2002 Week 45, International Pharmaceutical Abstracts 1970 to Oct 2002, PREMEDLINE Oct 27, 2002, MEDLINE 1996 to Oct Week 4 2002. We searched the keywords with Ovid software version rel6.2.0: 'soy', 'soy protein', 'soybean', 'tofu', 'phytoestrogen', 'isoflavone', 'genistein', 'daidzein', 'formononectin' and 'biochanin A' by the method described by Dickersin 1994 [<xref ref-type="bibr" rid="B4">4</xref>]. We did not restrict any languages during the searching. Hand searching was made by retrieving relevant articles from the obtained studies and unpublished data were obtained through contacting experts. We identified on-going trials by searching ClinicalTrials.gov, the UK National Research Register and Meta-register of controlled trials on the internet.</p>
      </sec>
      <sec>
        <title>Selection of eligible trials</title>
        <p>We included both single and double blind randomized controlled trials with baseline and after treatment values for synthesizing risk (mean) differences. The outcome measures were differences of serum total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C) and triglycerides (TG) between post-randomization baselines and after treatments. Eligible interventions were isoflavones tablets of single isolated component or any mixtures of genisteins, daidzein, formononectin and biochanin A. Isoflavones interventions in forms of soy protein supplements or diets were also included as long as they compared isoflavones containing treatments with isoflavones depleting controls. Treatments with soy polysaccharides, fiber, and phytosterols as their primary interventions were excluded.</p>
      </sec>
      <sec>
        <title>Validity assessment and data abstraction</title>
        <p>Two independent investigators reviewed the articles obtained without masking. There were no scorings to the included trials. Data were entered twice to reduce input errors. Inter-rater reliability was not performed. Data were abstracted with a designed form before analysis. Duplicated trials or studies with the same population were counted once to reduce the duplicated publication bias. Data disagreement between the two reviewers was resolved by discussion.</p>
      </sec>
      <sec>
        <title>Study characteristics</title>
        <p>The characteristics of the obtained studies were tabulated with subtypes of isoflavones interventions, subjects' serum lipids status, dosages of isoflavones and lengths of treatment. Sub-group analysis was performed with different forms of isoflavones interventions, such as isolated genistein or mixtures of isoflavones tablets versus placebo, isoflavones containing versus depleting soy protein diets. Sensitivity analysis was also made across different population characteristics and lengths of treatment. Funnel plots were used to detect possible publication bias or treatment heterogeneity across sample sizes.</p>
      </sec>
      <sec>
        <title>Quantitative data synthesis</title>
        <p>We obtained the risk differences (RD) from the post-randomization baselines and after-treatment values in each trial and calculated the pooled standard deviation of the RD as:</p>
        <p>
          <inline-graphic xlink:href="1475-2891-2-15-i1.gif"/>
        </p>
        <p>where n<sub>1 </sub>and SD<sub>1 </sub>were sample size and standard deviation from treatment and n<sub>2 </sub>and SD<sub>2 </sub>were from control. Inverse variance method was used to pool all trial results [<xref ref-type="bibr" rid="B6">6</xref>] with software 'Review Manager 4.2 [<xref ref-type="bibr" rid="B31">31</xref>]. Fixed-effects model was used as the method of combination and it was supplemented with random-effects model if necessary. Since log odds ratios were not available in the trials, funnel plots were plotted with standard errors against risk (mean) differences.</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <sec>
        <title>Trial flow</title>
        <p>The trial flow chart was illustrated in Figure <xref ref-type="fig" rid="F1">1</xref>. Seventeen studies [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B23">23</xref>] (21 comparisons) with 853 subjects were included in this meta-analysis. Reasons for exclusion were non-randomization, lack of control [<xref ref-type="bibr" rid="B24">24</xref>-<xref ref-type="bibr" rid="B27">27</xref>], insufficient original data and baseline values [<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>].</p>
        <fig position="float" id="F1">
          <label>Figure 1</label>
          <caption>
            <p><bold>Trial flow chart of including isoflavones studies. </bold>Databases generated 3542 potential eligible randomized controlled trials (RCT). After careful review, seventeen RCT (reference [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B23">23</xref>]) were included in this meta-analysis.</p>
          </caption>
          <graphic xlink:href="1475-2891-2-15-1"/>
        </fig>
      </sec>
      <sec>
        <title>Study characteristics</title>
        <p>The characteristics of the trials included were shown in Table <xref ref-type="table" rid="T1">1</xref>. The populations being studied were adults of age between 18 and 73. Soy phytoestrogens interventions varied from isoflavones tablets to isoflavones containing soy diets. Isoflavones tablets were introduced in 11 trials, soy capsule in 1 trial, isolated soy protein (ISP) in 3 trials, and soy foods in 2 trials. The average intake of isoflavones was 73 mg per day (ranging from 28.5 to 150 mg) and length of treatment was 10 weeks (ranging from 2 to 26 weeks). Three trials recruited hyperlipidemic subjects while 8 included participants with normolipidemia. Thirteen studies recruited female, two recruited male and two recruited subjects with both genders.</p>
        <table-wrap position="float" id="T1">
          <label>Table 1</label>
          <caption>
            <p>Characteristics of the 17 included studies. There were 9 crossover and 8 parallel studies. The isoflavones tablets introduced were mainly in aglycone form. The abbreviations were listed below table.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <td align="center">
                  <bold>Study</bold>
                </td>
                <td align="center">
                  <bold>Treatment (Rx) &#x2020;</bold>
                </td>
                <td align="center">
                  <bold>Isoflavones content in Rx (mg/d) &#x2021;</bold>
                </td>
                <td align="center">
                  <bold>Control</bold>
                </td>
                <td align="center">
                  <bold>Isoflavones content in control (mg/d)</bold>
                </td>
                <td align="center">
                  <bold>No. of subjects</bold>
                </td>
                <td align="center">
                  <bold>Lipid status &#xA7;</bold>
                </td>
                <td align="center">
                  <bold>Subject gender ||</bold>
                </td>
                <td align="center">
                  <bold>Length of treatment (weeks)</bold>
                </td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">*Calvert 1981 [<xref ref-type="bibr" rid="B7">7</xref>]</td>
                <td align="center">soy biscuits</td>
                <td align="center">NA</td>
                <td align="center">soy biscuits</td>
                <td align="center">0</td>
                <td align="center">10</td>
                <td align="center">H</td>
                <td align="center">male</td>
                <td align="center">4</td>
              </tr>
              <tr>
                <td align="left">Clifton-Bligh 2001(I) [<xref ref-type="bibr" rid="B8">8</xref>]</td>
                <td align="center">T</td>
                <td align="center">57</td>
                <td align="center">T</td>
                <td/>
                <td/>
                <td/>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">Clifton-Bligh 2001(II) [<xref ref-type="bibr" rid="B8">8</xref>]</td>
                <td align="center">T</td>
                <td align="center">85.5</td>
                <td/>
                <td align="center">28.5</td>
                <td align="center">46</td>
                <td align="center">B</td>
                <td align="center">female</td>
                <td align="center">26</td>
              </tr>
              <tr>
                <td align="left">Dewell 2002 [<xref ref-type="bibr" rid="B9">9</xref>]</td>
                <td align="center">T</td>
                <td align="center">150 G = 40; D = 50; glycosides = 60</td>
                <td align="center">placebo</td>
                <td align="center">0</td>
                <td align="center">36</td>
                <td align="center">H</td>
                <td align="center">female</td>
                <td align="center">24</td>
              </tr>
              <tr>
                <td align="left">Hale 2002 [<xref ref-type="bibr" rid="B10">10</xref>]</td>
                <td align="center">T</td>
                <td align="center">80 G = 40; D = 40</td>
                <td align="center">placebo</td>
                <td align="center">0</td>
                <td align="center">29</td>
                <td align="center">NS</td>
                <td align="center">post</td>
                <td align="center">2</td>
              </tr>
              <tr>
                <td align="left">Han 2002 [<xref ref-type="bibr" rid="B11">11</xref>]</td>
                <td align="center">soy protein capsule</td>
                <td align="center">100 G = 70; D = 18; glycitein = 12</td>
                <td align="center">soy protein capsule</td>
                <td align="center">0</td>
                <td align="center">78</td>
                <td align="center">N</td>
                <td align="center">peri</td>
                <td align="center">16</td>
              </tr>
              <tr>
                <td align="left">Hodgson 1998 [<xref ref-type="bibr" rid="B12">12</xref>]</td>
                <td align="center">T</td>
                <td align="center">55 G = 30; D = 1; B = 16; F = 8</td>
                <td align="center">placebo</td>
                <td align="center">0</td>
                <td align="center">59</td>
                <td align="center">N</td>
                <td align="center">male &amp; female</td>
                <td align="center">8</td>
              </tr>
              <tr>
                <td align="left">Howes 2000 [<xref ref-type="bibr" rid="B13">13</xref>]</td>
                <td align="center">T</td>
                <td align="center">40 G = 1; D = 0.5; B = 26; F = 16</td>
                <td align="center">placebo</td>
                <td align="center">0</td>
                <td align="center">75</td>
                <td align="center">NS</td>
                <td align="center">post</td>
                <td align="center">5</td>
              </tr>
              <tr>
                <td align="left">Mackey 2000 [<xref ref-type="bibr" rid="B14">14</xref>]</td>
                <td align="center">ISP</td>
                <td align="center">65</td>
                <td align="center">ISP</td>
                <td align="center">&lt; 4</td>
                <td align="center">49</td>
                <td align="center">H</td>
                <td align="center">post</td>
                <td align="center">12</td>
              </tr>
              <tr>
                <td align="left">*Merz-Demlow 2000(I) [<xref ref-type="bibr" rid="B15">15</xref>]</td>
                <td align="center">ISP</td>
                <td align="center">113&#x2013;144</td>
                <td align="center">ISP</td>
                <td/>
                <td/>
                <td/>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">*Merz-Demlow 2000(II) [<xref ref-type="bibr" rid="B15">15</xref>]</td>
                <td align="center">ISP</td>
                <td align="center">55&#x2013;74</td>
                <td/>
                <td align="center">9&#x2013;11</td>
                <td align="center">13</td>
                <td align="center">N</td>
                <td align="center">female</td>
                <td align="center">3</td>
              </tr>
              <tr>
                <td align="left">*Nestel 1997 [<xref ref-type="bibr" rid="B16">16</xref>]</td>
                <td align="center">T</td>
                <td align="center">40&#x2013;80 G= 22&#x2013;43; D = 17&#x2013;33; glycitein= 1&#x2013;3</td>
                <td align="center">placebo</td>
                <td align="center">0</td>
                <td align="center">21</td>
                <td align="center">B</td>
                <td align="center">female</td>
                <td align="center">5</td>
              </tr>
              <tr>
                <td align="left">*Nestel 1999(I) [<xref ref-type="bibr" rid="B17">17</xref>]</td>
                <td align="center">T</td>
                <td align="center">80 G = 8; D = 7; B = 49; F = 16</td>
                <td align="center">placebo</td>
                <td/>
                <td/>
                <td/>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">*Nestel 1999(II) [<xref ref-type="bibr" rid="B17">17</xref>]</td>
                <td align="center">T</td>
                <td align="center">40 G = 4; D = 3.5; B = 24.5; F = 8</td>
                <td/>
                <td align="center">0</td>
                <td align="center">13</td>
                <td align="center">B</td>
                <td align="center">female</td>
                <td align="center">5</td>
              </tr>
              <tr>
                <td align="left">*Samman 1999 [<xref ref-type="bibr" rid="B18">18</xref>]</td>
                <td align="center">T</td>
                <td align="center">86 G = 8.6; D = 7.4; B = 51.4; F = 18.6</td>
                <td align="center">placebo</td>
                <td align="center">0</td>
                <td align="center">14</td>
                <td align="center">N</td>
                <td align="center">pre</td>
                <td align="center">16</td>
              </tr>
              <tr>
                <td align="left">*Sanders 2002 [<xref ref-type="bibr" rid="B19">19</xref>]</td>
                <td align="center">soy burger</td>
                <td align="center">56 G = 34.8; D = 21.2</td>
                <td align="center">soy burger</td>
                <td align="center">2</td>
                <td align="center">22</td>
                <td align="center">N</td>
                <td align="center">male &amp; female</td>
                <td align="center">2</td>
              </tr>
              <tr>
                <td align="left">*Simons 2000 [<xref ref-type="bibr" rid="B20">20</xref>]</td>
                <td align="center">T</td>
                <td align="center">80</td>
                <td align="center">placebo</td>
                <td align="center">0</td>
                <td align="center">20</td>
                <td align="center">N</td>
                <td align="center">post</td>
                <td align="center">8</td>
              </tr>
              <tr>
                <td align="left">Squadrito 2002 [<xref ref-type="bibr" rid="B21">21</xref>]</td>
                <td align="center">T</td>
                <td align="center">54 G= 54</td>
                <td align="center">placebo</td>
                <td align="center">0</td>
                <td align="center">60</td>
                <td align="center">N</td>
                <td align="center">female</td>
                <td align="center">24</td>
              </tr>
              <tr>
                <td align="left">*Urban 2001 [<xref ref-type="bibr" rid="B22">22</xref>]</td>
                <td align="center">T</td>
                <td align="center">70 G = 42; D = 27</td>
                <td align="center">ISP</td>
                <td align="center">3</td>
                <td align="center">28</td>
                <td align="center">N</td>
                <td align="center">elderly men</td>
                <td align="center">6</td>
              </tr>
              <tr>
                <td align="left">*Wangen 2001(I) [<xref ref-type="bibr" rid="B23">23</xref>]</td>
                <td align="center">ISP</td>
                <td align="center">110&#x2013;154</td>
                <td align="center">ISP</td>
                <td/>
                <td/>
                <td/>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">*Wangen 2001(II) [<xref ref-type="bibr" rid="B23">23</xref>]</td>
                <td align="center">ISP</td>
                <td align="center">54&#x2013;76</td>
                <td/>
                <td align="center">6&#x2013;8.2</td>
                <td align="center">18</td>
                <td align="center">NS</td>
                <td align="center">post</td>
                <td align="center">4</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>* crossover design &#x2020; 'T' = isoflavone tablet; 'ISP' = isolated soy protein &#x2021; 'G' = Genistein; 'D' = Daidzein; 'B' = Biochanin A; 'F' = Formononectin &#xA7;'H' = hyperlipidemic subjects, 'N' = normolipidemic subjects; 'B' = both hyper- and normolipidemic subjects; 'NS' = not specified || 'pre' = premenopausal women; 'peri' = perimenopausal women; 'post' = postmenopausal women</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Quantitative data synthesis</title>
        <p>We found that isoflavones tablets insignificantly increased serum TC by 0.01 mmol/L (95% CI = -0.17 to 0.18; heterogeneity p = 1.0) (Figure <xref ref-type="fig" rid="F2">2</xref>); LDL by 0.00 mmol/L (95% CI = -0.14 to 0.15; heterogeneity p = 0.9); HDL by 0.01 mmol/L (95% CI = -0.05 to 0.06; heterogeneity p = 1.0); and triglyceride by 0.03 mmol/L (95% CI = -0.06 to 0.12; heterogeneity p = 0.9). Isoflavones containing soy biscuits or burger had insignificant effects on serum TC with reference to isoflavones depleting soy biscuits or burger. Only isoflavones containing isolated soy protein (ISP) or soy protein (SP) capsule reduced serum TC when compared with isoflavones depleting ISP or SP capsule (Table <xref ref-type="table" rid="T2">2</xref>). There was only one trial [<xref ref-type="bibr" rid="B11">11</xref>] introduced SP capsule as treatment. Mixtures of the four soy phytoestrogens (genistein, daidzein, formononectin and biochanin A) or isolated genistein did not have significant effects on serum TC. The significant result from intervening the mixtures of genistein and daidzein had shown to be statistically heterogeneous to combine (heterogeneity p = 0.06) as genistein and daidzein tablets were introduced among 3 studies [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B16">16</xref>] while Sanders [<xref ref-type="bibr" rid="B19">19</xref>] chose genistein and daidzein soy burger and Urban [<xref ref-type="bibr" rid="B22">22</xref>] used genistein and daidzein ISP. In subgroup analysis, the effect of genistein and daidzein tablets on serum TC from the 3 studies was shown to be insignificant, 0.1 mmol/L (95% CI = -0.25 to 0.45; heterogeneity p = 0.87). Dose-response effect was not found in any forms of interventions in this meta-analysis. The results remained insignificant when the length of treatment increased. Although one trial [<xref ref-type="bibr" rid="B22">22</xref>] (without washout period) produced significant effect, it seemed that study design had no influence on the serum TC. There were insignificant decreases of serum TC among pre- and postmenopausal women. Interestingly, cholesterol lowering effects could only be found among normolipidemic subjects but not participants with hyperlipidemia and men were shown to be benefited with isoflavones treatment. Isoflavones in the forms of tablets and ISP were all insignificant on serum low density lipoprotein cholesterol (LDL), high density lipoprotein cholesterol (HDL) and triglycerides (TG). These results were shown in Table <xref ref-type="table" rid="T3">3</xref>. Funnel plots of isoflavones tablets were asymmetrical and the results of the published trials tended to favor treatment.</p>
        <fig position="float" id="F2">
          <label>Figure 2</label>
          <caption>
            <p><bold>Funnel plot of risk difference of isoflavones tablets versus placebo on serum total cholesterol. </bold>Total treatment size was 274 and total control was 208. The pooled risk difference of isoflavones tablets versus placebo was 0.01 with 95% confidence interval between -0.17 and 0.18. Heterogeneity p-value was 1.00. Note: 'N' = sample size; 'SD' = standard deviation; 'RD' = risk difference; '95% CI' = 95% confidence interval</p>
          </caption>
          <graphic xlink:href="1475-2891-2-15-2"/>
        </fig>
        <table-wrap position="float" id="T2">
          <label>Table 2</label>
          <caption>
            <p>Subgroup analysis of the effects of isoflavones on serum total cholesterol. Isoflavones were shown to have significant benefits when given in the form of ISP or soy protein capsule. Regardless the forms of prescription, isoflavones decreased serum total cholesterol among normolipidemic but not hyperlipidemic subjects.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <td align="center">Subgroup outcome</td>
                <td align="center">No. of comparisons</td>
                <td align="center">No. of subjects ||</td>
                <td align="center">Treatment effect on TC (mmol/L) &#xB6;</td>
                <td align="center">Heterogeneity p-value &#xA7;</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Form of intervention &#x2020;:</td>
                <td/>
                <td/>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">&#x2003;a.) isoflavones tablets</td>
                <td align="left">12 [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]</td>
                <td align="center">482</td>
                <td align="center">0.01 (-0.17, 0.18)</td>
                <td align="center">1.00</td>
              </tr>
              <tr>
                <td align="left">&#x2003;b.) ISP(+)</td>
                <td align="left">8 [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>]</td>
                <td align="center">229</td>
                <td align="center">-0.11 (-0.21, -0.01)*</td>
                <td align="center">0.34</td>
              </tr>
              <tr>
                <td align="left">&#x2003;c.) soy protein capsule</td>
                <td align="left">1 [<xref ref-type="bibr" rid="B11">11</xref>]</td>
                <td align="center">78</td>
                <td align="center">-0.69 (-1.19, -0.19)*</td>
                <td align="center">NA</td>
              </tr>
              <tr>
                <td align="left">&#x2003;d.) soy biscuit</td>
                <td align="left">1 [<xref ref-type="bibr" rid="B7">7</xref>]</td>
                <td align="center">20</td>
                <td align="center">-0.05 (-0.47, 0.37)</td>
                <td align="center">NA</td>
              </tr>
              <tr>
                <td align="left">&#x2003;e.) soy burger</td>
                <td align="left">1 [<xref ref-type="bibr" rid="B19">19</xref>]</td>
                <td align="center">44</td>
                <td align="center">0.09 (-0.38, 0.56)</td>
                <td align="center">NA</td>
              </tr>
              <tr>
                <td align="left">&#x2003;f.) Overall</td>
                <td align="left">21 [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B23">23</xref>]</td>
                <td align="center">853</td>
                <td align="center">-0.09 (-0.18, -0.01)*</td>
                <td align="center">0.77</td>
              </tr>
              <tr>
                <td align="left">Isoflavones mixture &#x2021;:</td>
                <td/>
                <td/>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">&#x2003;G&amp;D&amp;B&amp;F</td>
                <td align="left">5 [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>]</td>
                <td align="center">214</td>
                <td align="center">-0.06 (-0.34, 0.21)</td>
                <td align="center">0.96</td>
              </tr>
              <tr>
                <td align="left">&#x2003;G&amp;D</td>
                <td align="left">6 [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B22">22</xref>]</td>
                <td align="center">285</td>
                <td align="center">-0.22 (-0.41, -0.03)*</td>
                <td align="center">0.06</td>
              </tr>
              <tr>
                <td align="left">&#x2003;G</td>
                <td align="left">1 [<xref ref-type="bibr" rid="B21">21</xref>]</td>
                <td align="center">60</td>
                <td align="center">0.10 (-0.35, 0.55)</td>
                <td align="center">NA</td>
              </tr>
              <tr>
                <td align="left">Isoflavones intake (mg per day):</td>
                <td/>
                <td/>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">&#x2003;&lt; 50</td>
                <td align="left">3 [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B17">17</xref>]</td>
                <td align="center">132</td>
                <td align="center">-0.12 (-0.54, 0.29)</td>
                <td align="center">0.99</td>
              </tr>
              <tr>
                <td align="left">&#x2003;51&#x2013;100</td>
                <td align="left">12 [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B23">23</xref>]</td>
                <td align="center">484</td>
                <td align="center">-0.10 (-0.21,0.01)</td>
                <td align="center">0.74</td>
              </tr>
              <tr>
                <td align="left">&#x2003;101 &#x2013; 150</td>
                <td align="left">4 [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B23">23</xref>]</td>
                <td align="center">176</td>
                <td align="center">-0.10 (-0.24, 0.05)</td>
                <td align="center">0.09</td>
              </tr>
              <tr>
                <td align="left">Design :</td>
                <td/>
                <td/>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">&#x2003;parallel crossover</td>
                <td align="left">9 [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B21">21</xref>]</td>
                <td align="center">447</td>
                <td align="center">-0.08 (-0.27, 0.10)</td>
                <td align="center">0.48</td>
              </tr>
              <tr>
                <td align="left">&#x2003;&#x2003;a.) no washout</td>
                <td align="left">1 [<xref ref-type="bibr" rid="B22">22</xref>]</td>
                <td align="center">56</td>
                <td align="center">-0.43 (-0.73, -0.13)*</td>
                <td align="center">NA</td>
              </tr>
              <tr>
                <td align="left">&#x2003;&#x2003;b.) washout mentioned</td>
                <td align="left">6 [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B23">23</xref>]</td>
                <td align="center">208</td>
                <td align="center">-0.07 (-0.17, 0.03)</td>
                <td align="center">0.91</td>
              </tr>
              <tr>
                <td align="left">Gender:</td>
                <td/>
                <td/>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">&#x2003;male</td>
                <td align="left">2 [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B22">22</xref>]</td>
                <td align="center">76</td>
                <td align="center">-0.30 (-0.54, -0.05)*</td>
                <td align="center">0.15</td>
              </tr>
              <tr>
                <td align="left">&#x2003;female</td>
                <td align="left">17 [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B23">23</xref>]</td>
                <td align="center">674</td>
                <td align="center">-0.07 (-0.17, 0.02)</td>
                <td align="center">0.89</td>
              </tr>
              <tr>
                <td align="left">Treatment length:</td>
                <td/>
                <td/>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">&#x2003;2&#x2013;10 weeks</td>
                <td align="left">14[<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>]</td>
                <td align="center">541</td>
                <td align="center">-0.09 (-0.18, 0.00)</td>
                <td align="center">0.84</td>
              </tr>
              <tr>
                <td align="left">&#x2003;11&#x2013;20 weeks</td>
                <td align="left">3 [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B18">18</xref>]</td>
                <td align="center">155</td>
                <td align="center">-0.22 (-0.52, 0.07)</td>
                <td align="center">0.07</td>
              </tr>
              <tr>
                <td align="left">&#x2003;21&#x2013;30 weeks</td>
                <td align="left">4 [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B21">21</xref>]</td>
                <td align="center">157</td>
                <td align="center">0.02 (-0.28, 0.31)</td>
                <td align="center">0.96</td>
              </tr>
              <tr>
                <td align="left">Menopausal status:</td>
                <td/>
                <td/>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">&#x2003;pre-menopausal</td>
                <td align="left">3 [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B18">18</xref>]</td>
                <td align="center">80</td>
                <td align="center">-0.06 (-0.17, 0.06)</td>
                <td align="center">0.58</td>
              </tr>
              <tr>
                <td align="left">&#x2003;peri-menopausal</td>
                <td align="left">1 [<xref ref-type="bibr" rid="B11">11</xref>]</td>
                <td align="center">78</td>
                <td align="center">-0.69 (-1.19, -0.19)*</td>
                <td align="center">NA</td>
              </tr>
              <tr>
                <td align="left">&#x2003;post-menopausal</td>
                <td align="left">13 [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B23">23</xref>]</td>
                <td align="center">516</td>
                <td align="center">-0.05 (-0.20, 0.10)</td>
                <td align="center">1.00</td>
              </tr>
              <tr>
                <td align="left">Subjects with:</td>
                <td/>
                <td/>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">&#x2003;normolipidemia</td>
                <td align="left">8 [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]</td>
                <td align="center">377</td>
                <td align="center">-0.11 (-0.21, -0.01)*</td>
                <td align="center">0.08</td>
              </tr>
              <tr>
                <td align="left">&#x2003;hyperlipidemia</td>
                <td align="left">3 [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B14">14</xref>]</td>
                <td align="center">105</td>
                <td align="center">-0.05 (-0.36, 0.26)</td>
                <td align="center">1.00</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>* statistically significant &#x2020; 'ISP (+)' = isoflavone containing isolated soy protein; 'ISP (-)' = isoflavone depleting isolated soy protein &#x2021; 'G' = Genistein; 'D' = Daidzein; 'B' = Biochanin A; 'F' = Formononectin &#xA7; NA = not applicable || Since subjects acted as their own controls in a crossover trial, the 'calculated' total number was thus doubled in a single pair comparison. &#xB6; 95% confidence interval in parenthesis</p>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap position="float" id="T3">
          <label>Table 3</label>
          <caption>
            <p>Effects of isoflavones on serum LDL-cholesterol, HDL-cholesterol and triglycerides levels. Isoflavones in the forms of tablets or isolated soy protein (ISP) did not show significant benefits over serum LDL-cholesterol, HDL-cholesterol and triglycerides levels. The results were not heterogeneous to combine.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <td align="center">
                  <bold>Type of intervention*</bold>
                </td>
                <td align="center">
                  <bold>No. of trials</bold>
                </td>
                <td align="center">
                  <bold>No. of comparisons</bold>
                </td>
                <td align="center">
                  <bold>No. of subjects</bold>
                </td>
                <td align="center"><bold>Treatment effect </bold>(mmol/L) &#x2020;</td>
                <td align="center">
                  <bold>Heterogeneity p-value</bold>
                </td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">1.) Isoflavones tablets</td>
                <td/>
                <td/>
                <td/>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">&#x2003;LDL</td>
                <td align="center">9</td>
                <td align="left">11[<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]</td>
                <td align="center">446</td>
                <td align="center">0.00 (-0.14, 0.15)</td>
                <td align="center">0.94</td>
              </tr>
              <tr>
                <td align="left">&#x2003;HDL</td>
                <td align="center">10</td>
                <td align="left">12[<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]</td>
                <td align="center">482</td>
                <td align="center">0.01 (-0.05, 0.06)</td>
                <td align="center">0.98</td>
              </tr>
              <tr>
                <td align="left">&#x2003;TG</td>
                <td align="center">9</td>
                <td align="left">12[<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]</td>
                <td align="center">482</td>
                <td align="center">0.03 (-0.06, 0.12)</td>
                <td align="center">0.93</td>
              </tr>
              <tr>
                <td align="left">2.) ISP (+)</td>
                <td/>
                <td/>
                <td/>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">&#x2003;LDL</td>
                <td align="center">3</td>
                <td align="left">5 [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B23">23</xref>]</td>
                <td align="center">173</td>
                <td align="center">-0.06 (-0.16, 0.03)</td>
                <td align="center">0.84</td>
              </tr>
              <tr>
                <td align="left">&#x2003;HDL</td>
                <td align="center">3</td>
                <td align="left">5 [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B23">23</xref>]</td>
                <td align="center">173</td>
                <td align="center">-0.01 (-0.07, 0.05)</td>
                <td align="center">0.97</td>
              </tr>
              <tr>
                <td align="left">&#x2003;TG</td>
                <td align="center">3</td>
                <td align="left">5 [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B23">23</xref>]</td>
                <td align="center">173</td>
                <td align="center">0.02 (-0.05, 0.09)</td>
                <td align="center">1.00</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>* 'ISP (+)' = isoflavones containing isolated soy protein; 'LDL' = Low density lipoprotein cholesterol; 'HDL' = High density lipoprotein cholesterol; 'TG' = Triglycerides &#x2020; 95% confidence interval in parenthesis</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <sec>
        <title>Main findings</title>
        <p>Phytoestrogens with either isolated genistein or isoflavones mixtures of genistein, daidzein, formononectin and biochanin A were found to be statistically insignificant in lowering serum total cholesterol (Table <xref ref-type="table" rid="T2">2</xref>). Resolving the heterogeneity from pooling the mixtures of genistein and daidzein, we found that tablets prescription with these two isoflavones [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B16">16</xref>] yielded insignificant benefits over serum TC, 0.1 mmol/L (95% CI = -0.25 to 0.45; heterogeneity p-value = 0.87). One trial [<xref ref-type="bibr" rid="B19">19</xref>], introducing soy burger as the prescription of these 2 isoflavones, found insignificant benefits. Another trial [<xref ref-type="bibr" rid="B22">22</xref>], prescribing them in the form of isolated soy protein (ISP), had shown a decrease in serum TC by 0.43 mmol/L (95% CI = -0.73 to -0.13). It may be a result of bias as this trial lacked a washout period. When dose-response effect and treatment length were taken into account, phytoestrogens seemed to have insignificant effects over serum cholesterol (Table <xref ref-type="table" rid="T2">2</xref>). Isoflavones in the forms of tablets, soy burger or biscuits seemed to have insignificant benefits over serum TC. Only Han [<xref ref-type="bibr" rid="B11">11</xref>] reported a significant benefit for isoflavones in the form of soy protein capsule. Isoflavones in the forms of tablets or ISP could not be shown to have significant benefits over serum low density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol and triglycerides (TG) (Table <xref ref-type="table" rid="T3">3</xref>).</p>
        <p>We could not demonstrate significant benefits with all types of prescriptions when the dosages or treatment lengths increased. No dose-response effect was detected nor benefits on serum cholesterol with any forms of prescription among pre- and post-menopausal women and hyperlipidemic subjects. The benefit over normolipidemic subjects was heterogeneous (p = 0.08). It may be again the result of prescription diversity. Separated analysis found that isoflavones tablets [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B21">21</xref>] had insignificant effect on serum TC among normolipidemic subjects, 0.05 mmol/L (95% CI = -0.23 to 0.33; heterogeneity p = 0.9). Only isoflavones in the form of soy protein capsule [<xref ref-type="bibr" rid="B11">11</xref>] or ISP [<xref ref-type="bibr" rid="B22">22</xref>] reported benefits on participants with normolidemia. In fact, some suggest that the beneficial effects of soy protein require synergistic reactions between isoflavones and other soy components [<xref ref-type="bibr" rid="B32">32</xref>]. This hypothesis was supported by some animal experiments [<xref ref-type="bibr" rid="B33">33</xref>-<xref ref-type="bibr" rid="B35">35</xref>]. It seemed that isoflavones in the form of tablets, up to 150 mg per day (genistein about 50 mg, daidzein about 50 mg), had no significant benefits on serum cholesterols in this meta-analysis. Phytoestrogens treatments in forms of soy protein supplements or soy protein capsule may need further investigations, especially interactions between other chemically active components inside prescriptions.</p>
      </sec>
      <sec>
        <title>Validity and limitation</title>
        <p>In subgroup analysis, the sample sizes were inevitably reduced and there might be insufficient power to detect small significant differences. Isoflavones treatments with dosages beyond 150 mg per day or treatment lengths beyond 26 weeks could not be shown in this study. The effects on serum cholesterols among subjects with hypertension, diabetes mellitus or other cardiovascular risk factors were also beyond this meta-analysis. Generalizability over other phytoestrogens such as coumestans, lignans and resveratrol may need further trials to clarify the questions. No funnel plots were shown in this study because the choice of risk differences as the horizontal axes may lead to funnel plot asymmetry [<xref ref-type="bibr" rid="B36">36</xref>]. Publication bias was still possible although vigorous searching had been attempted.</p>
      </sec>
      <sec>
        <title>Biological plausibility</title>
        <p>It was suggested that isoflavones readily bind estrogen receptors &#x2013; beta (ER-beta) which are an important receptors in both the central nervous and cardiovascular systems [<xref ref-type="bibr" rid="B37">37</xref>-<xref ref-type="bibr" rid="B39">39</xref>]. Isoflavones may also have anti-oxidant effects on blood vessels [<xref ref-type="bibr" rid="B40">40</xref>-<xref ref-type="bibr" rid="B42">42</xref>]. However, compared with estradiol, isoflavones bind estrogen receptors with 100 and 1,000 times less affinity [<xref ref-type="bibr" rid="B30">30</xref>]. Both conjugated and aglycone forms of daidzein and genistein are rapidly cleared from the plasma following a single dose of isoflavones [<xref ref-type="bibr" rid="B43">43</xref>] and urinary excretion is virtually nil within 48 hours after ingestion [<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B45">45</xref>]. Biological effects of soy phytoestrogens are still controversial. The hypothesis from an influential meta-analysis [<xref ref-type="bibr" rid="B1">1</xref>] stating soy estrogens may be responsible for the lipid reduction effects was criticized for the fact that the trials involved largely isoflavone-free soy protein products [<xref ref-type="bibr" rid="B46">46</xref>]. Apart from phytoestrogens, in fact, some other components such as phytic acid, saponins and fibers were potential candidates responsible for the hypocholesterolemic effects [32,48,49].</p>
      </sec>
      <sec>
        <title>Suggestion to future trials</title>
        <p>Tablets of single isolated isoflavone with considerable dosages may be important in future randomized trials. Intervention with isoflavones mixtures may be helpful but interactions between components should be handled with extra cares. Introduction of phytoestrogens in forms of soy diets is not suggested because we found much heterogeneity inside the diets, ranging from soy biscuits to burger, which may be difficult to combine and analyze. Confounding factors such as fiber, fatty acids, amino acids and energy intake are especially hard to control. Complications associated with hyperlipidemia, such as coronary heart disease (CHD) or cardiovascular accident (CVA), may be selected as other endpoints in future trials. It may help constructing convincing funnel plots with less heterogeneity as trials accumulate.</p>
      </sec>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>Isoflavones tablets, up to 150 mg per day, had insignificant effects in lowering serum total cholesterol, LDL-cholesterol and triglyceride. There was also insignificant benefit over serum HDL-cholesterol. The results were consistent when tablets were introduced as isolated genistein, mixture of genistein and daidzein, or mixture of genistein, daidzein, formononectin and biochanin A. No significant effects were found among participants with normo- or hyperlipidemia and women with pre- or postmenopausal status. Isoflavones interventions in the forms of soy proteins, such as isolated soy protein (ISP), soy diets or soy protein capsule, were inconclusive due to inadequate sample size, heterogeneity and presence of potentially uncontrolled confounders.</p>
    </sec>
    <sec>
      <title>List of abbreviations</title>
      <p>'ISP' = isolated soy protein; 'TC' = total cholesterol; 'LDL' = Low density lipoprotein cholesterol; 'HDL' = High density lipoprotein cholesterol; 'TG' = Triglycerides</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>None declared.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>JY participated in the design of this manuscript. JY and YTF participated in abstracted the data and performed statistical analysis. All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Johnstone</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Cook-Newell</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>Meta-analysis of the effects of soy protein intake on serum lipids</article-title>
          <source>N Eng J Med</source>
          <year>1995</year>
          <volume>333</volume>
          <fpage>276</fpage>
          <lpage>282</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM199508033330502</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hasler</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>The cardiovascular effects of soy products</article-title>
          <source>J Cardiovasc Nurs</source>
          <year>2002</year>
          <volume>16</volume>
          <fpage>50</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">12597262</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clarkson</surname>
              <given-names>TB</given-names>
            </name>
          </person-group>
          <article-title>Fourth international symposium on the role of soy in preventing and treating chronic disease: Soy, soy phytoestrogens and cardiovascular disease</article-title>
          <source>J Nutr</source>
          <year>2002</year>
          <volume>suppl 132</volume>
          <fpage>566</fpage>
          <lpage>569S</lpage>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dickersin</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Scherer</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lefebvre</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Systematic Reviews: Identifying relevant studies for systematic reviews</article-title>
          <source>BMJ</source>
          <year>1994</year>
          <volume>309</volume>
          <fpage>1286</fpage>
          <lpage>1291</lpage>
          <pub-id pub-id-type="pmid">7718048</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Phipps</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Duncan</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Kurzer</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>A Critical Review: Isoflavones and Postmenopausal Women</article-title>
          <source>Treat Endocrinol</source>
          <year>2002</year>
          <volume>1</volume>
          <fpage>293</fpage>
          <lpage>311</lpage>
          <pub-id pub-id-type="pmid">15832484</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Deeks</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Altman</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Bradburn</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Egger M, Smith GD, Altman DG</surname>
            </name>
          </person-group>
          <article-title>Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis</article-title>
          <source>In Systematic Reviews in Health Care: Meta-analysis in Context</source>
          <year>2001</year>
          <edition>2</edition>
          <publisher-name>London: BMJ Publishing Group</publisher-name>
          <fpage>285</fpage>
          <lpage>312</lpage>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Calvert</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Blight</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Illman</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Topping</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Potter</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>A trial of the effects of soya-bean flour and soya-bean saponins on plasma lipids, faecal bile acids and neutral sterols in hypercholesterolaemic men</article-title>
          <source>Br J Nutr</source>
          <year>1981</year>
          <volume>45</volume>
          <fpage>277</fpage>
          <lpage>281</lpage>
          <pub-id pub-id-type="pmid">7011362</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clifton-Bligh</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Baber</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Fulcher</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Nery</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Moreton</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism</article-title>
          <source>Menopause</source>
          <year>2001</year>
          <volume>8</volume>
          <fpage>259</fpage>
          <lpage>265</lpage>
          <pub-id pub-id-type="pmid">11449083</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dewell</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hollenbeck</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Bruce</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2002</year>
          <volume>87</volume>
          <fpage>118</fpage>
          <lpage>121</lpage>
          <pub-id pub-id-type="pmid">11788633</pub-id>
          <pub-id pub-id-type="doi">10.1210/jc.87.1.118</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hale</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Paul-Labrador</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dwyer</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Merz</surname>
              <given-names>CNB</given-names>
            </name>
          </person-group>
          <article-title>Isoflavone supplementation and endothelial function in menopausal women</article-title>
          <source>Clin Endocrinol</source>
          <year>2002</year>
          <volume>56</volume>
          <fpage>693</fpage>
          <lpage>701</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-2265.2002.01533.x</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Soares</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Haidar</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>de Lima</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Baracat</surname>
              <given-names>EC</given-names>
            </name>
          </person-group>
          <article-title>Benefits of soy isoflavone therapeutic regimen on menopausal symptoms</article-title>
          <source>Obstet Gynecol</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>389</fpage>
          <lpage>394</lpage>
          <pub-id pub-id-type="pmid">11864664</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0029-7844(01)01744-6</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hodgson</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Puddey</surname>
              <given-names>IB</given-names>
            </name>
            <name>
              <surname>Beilin</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Croft</surname>
              <given-names>KD</given-names>
            </name>
          </person-group>
          <article-title>Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans</article-title>
          <source>J Nutr</source>
          <year>1998</year>
          <volume>128</volume>
          <fpage>728</fpage>
          <lpage>732</lpage>
          <pub-id pub-id-type="pmid">9521635</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Howes</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Sullivan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nestel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pomeroy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Eden</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Howes</surname>
              <given-names>LG</given-names>
            </name>
          </person-group>
          <article-title>The effects of dietary supplementation with isoflavones from red clover on the lipoprotein protein profiles of post menopausal women with mild to moderate hypercholesterolaemia</article-title>
          <source>Atherosclerosis</source>
          <year>2000</year>
          <volume>152</volume>
          <fpage>143</fpage>
          <lpage>147</lpage>
          <pub-id pub-id-type="pmid">10996349</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0021-9150(99)00437-2</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mackey</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ekangaki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Eden</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>The effects of soy protein in women and men with elevated plasma lipids</article-title>
          <source>Biofactors</source>
          <year>2000</year>
          <volume>12</volume>
          <fpage>251</fpage>
          <lpage>257</lpage>
          <pub-id pub-id-type="pmid">11216493</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Merz-Demlow</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Duncan</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Wangen</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Carr</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Phipps</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Kurzer</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women</article-title>
          <source>Am J Clin Nutr</source>
          <year>2000</year>
          <volume>71</volume>
          <fpage>1462</fpage>
          <lpage>1469</lpage>
          <pub-id pub-id-type="pmid">10837286</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nestel</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Yamashita</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sasahara</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Pomeroy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dart</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Komesaroff</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Owen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Abbey</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women</article-title>
          <source>ArteriosclerThromb Vasc Biol</source>
          <year>1997</year>
          <volume>17</volume>
          <fpage>3392</fpage>
          <lpage>3398</lpage>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nestel</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Pomeroy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kay</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Komesaroff</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Behrsing</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cameron</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>1999</year>
          <volume>84</volume>
          <fpage>895</fpage>
          <lpage>898</lpage>
          <pub-id pub-id-type="pmid">10084567</pub-id>
          <pub-id pub-id-type="doi">10.1210/jc.84.3.895</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Samman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wall</surname>
              <given-names>PML</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>GSM</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Petocz</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>The effect of supplementation with isoflavones on plasma lipids and oxidisability of low density lipoprotein in premenopausal women</article-title>
          <source>Atherosclerosis</source>
          <year>1999</year>
          <volume>147</volume>
          <fpage>277</fpage>
          <lpage>283</lpage>
          <pub-id pub-id-type="pmid">10559513</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0021-9150(99)00196-3</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanders</surname>
              <given-names>TAB</given-names>
            </name>
            <name>
              <surname>Dean</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Grainger</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Wiseman</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Moderate intakes of intact soy protein rich in isoflavones compared with ethanol-extracted soy protein increase HDL but do not influence transforming growth factor beta concentrations and hemostatic risk factors for coronary heart disease in healthy subjects</article-title>
          <source>Am J Clin Nutr</source>
          <year>2002</year>
          <volume>76</volume>
          <fpage>373</fpage>
          <lpage>377</lpage>
          <pub-id pub-id-type="pmid">12145009</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simons</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>von Konigsmark</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Simons</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Celermajer</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <article-title>Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women</article-title>
          <source>Am J Cardiol</source>
          <year>2000</year>
          <volume>85</volume>
          <fpage>1297</fpage>
          <lpage>1301</lpage>
          <pub-id pub-id-type="pmid">10831943</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0002-9149(00)00759-1</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Squadrito</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Altavilla</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Morabito</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Crisafulli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>D'Anna</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Corrado</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ruggeri</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Campo</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Calapai</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Caputi</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Squadrito</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women</article-title>
          <source>Atherosclerosis</source>
          <year>2002</year>
          <volume>163</volume>
          <fpage>339</fpage>
          <lpage>347</lpage>
          <pub-id pub-id-type="pmid">12052481</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0021-9150(02)00013-8</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Urban</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Irwin</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Kirk</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Markiewicz</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Myers</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Grizzle</surname>
              <given-names>WE</given-names>
            </name>
            <name>
              <surname>Barnes</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen</article-title>
          <source>J Urol</source>
          <year>2001</year>
          <volume>165</volume>
          <fpage>294</fpage>
          <lpage>300</lpage>
          <pub-id pub-id-type="pmid">11125428</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wangen</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Duncan</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Kurzer</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women</article-title>
          <source>Am J Clin Nutr</source>
          <year>2001</year>
          <volume>73</volume>
          <fpage>225</fpage>
          <lpage>231</lpage>
          <pub-id pub-id-type="pmid">11157317</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cassidy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bingham</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Setchell</surname>
              <given-names>KDR</given-names>
            </name>
          </person-group>
          <article-title>Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women</article-title>
          <source>Am J Clin Nutr</source>
          <year>1994</year>
          <volume>60</volume>
          <fpage>333</fpage>
          <lpage>340</lpage>
          <pub-id pub-id-type="pmid">8074062</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cassidy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bingham</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Setchell</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products</article-title>
          <source>Br J Nutr</source>
          <year>1995</year>
          <volume>74</volume>
          <fpage>587</fpage>
          <lpage>601</lpage>
          <pub-id pub-id-type="pmid">7577895</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tikkanen</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Wahala</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ojala</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Vihma</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Adlercreutz</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1998</year>
          <volume>95</volume>
          <fpage>3106</fpage>
          <lpage>3110</lpage>
          <pub-id pub-id-type="pmid">9501223</pub-id>
          <pub-id pub-id-type="doi">10.1073/pnas.95.6.3106</pub-id>
        </citation>
      </ref>
      <ref id="B27">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>WW</given-names>
            </name>
          </person-group>
          <article-title>Effects of soy isoflavones on blood lipids, blood pressure and biochemical markers of bone metabolism in postmenopausal women</article-title>
          <source>J Nutr</source>
          <year>2000</year>
          <volume>suppl 130</volume>
          <fpage>686S</fpage>
        </citation>
      </ref>
      <ref id="B28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gooderham</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Adlercreutz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ojala</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Wahala</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Holub</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>A soy protein isolate rich in genistein adn daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men</article-title>
          <source>J Nutr</source>
          <year>1996</year>
          <volume>126</volume>
          <fpage>2000</fpage>
          <lpage>2006</lpage>
          <pub-id pub-id-type="pmid">8759372</pub-id>
        </citation>
      </ref>
      <ref id="B29">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Potter</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Baum</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Teng</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Stillman</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Shay</surname>
              <given-names>NF</given-names>
            </name>
            <name>
              <surname>Erdman</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women</article-title>
          <source>Am J Clin Nutr</source>
          <year>1998</year>
          <volume>suppl 68</volume>
          <fpage>1375</fpage>
          <lpage>1379S</lpage>
        </citation>
      </ref>
      <ref id="B30">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adlercruetz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Goldin</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Gorbach</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Hockerstedt</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hamalainen</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Markkanen</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Makela</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Wahala</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Adlercreutz</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Soybean phytoestrogen intake and cancer risk</article-title>
          <source>J Nutr</source>
          <year>1995</year>
          <volume>suppl 125</volume>
          <fpage>757</fpage>
          <lpage>770S</lpage>
        </citation>
      </ref>
      <ref id="B31">
        <citation citation-type="other">
          <article-title>Review Manager (RevMan) [Computer program]. Version 4.2 for Windows</article-title>
          <source>Oxford, England: The Cochrane Collaboration</source>
          <year>2003</year>
        </citation>
      </ref>
      <ref id="B32">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Erdman</surname>
              <given-names>JW</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>AHA science advisory: soy protein and cardiovascular disease: a statement for healthcare professionals from the Nutrition Committee of the AHA</article-title>
          <source>Circulation</source>
          <year>2000</year>
          <volume>102</volume>
          <fpage>2555</fpage>
          <lpage>2559</lpage>
          <pub-id pub-id-type="pmid">11076833</pub-id>
        </citation>
      </ref>
      <ref id="B33">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clarkson</surname>
              <given-names>TB</given-names>
            </name>
          </person-group>
          <article-title>Soy, soy phytoestrogens and cardiovascular disease</article-title>
          <source>J Nutr</source>
          <year>2002</year>
          <volume>suppl 132</volume>
          <fpage>566</fpage>
          <lpage>569S</lpage>
        </citation>
      </ref>
      <ref id="B34">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clarkson</surname>
              <given-names>TB</given-names>
            </name>
            <name>
              <surname>Anthony</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>TM</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2001</year>
          <volume>86</volume>
          <fpage>41</fpage>
          <lpage>47</lpage>
          <pub-id pub-id-type="pmid">11231976</pub-id>
          <pub-id pub-id-type="doi">10.1210/jc.86.1.41</pub-id>
        </citation>
      </ref>
      <ref id="B35">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Clarkson</surname>
              <given-names>TB</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Wagner</surname>
              <given-names>JD</given-names>
            </name>
            <etal/>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Douglas PS</surname>
            </name>
          </person-group>
          <article-title>Lessons from animal models</article-title>
          <source>In Cardiovascular disease and disease in women</source>
          <year>2002</year>
          <edition>2</edition>
          <publisher-name>New York: WB Saunders Company</publisher-name>
          <fpage>231</fpage>
          <lpage>256</lpage>
        </citation>
      </ref>
      <ref id="B36">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sterne</surname>
              <given-names>JAC</given-names>
            </name>
            <name>
              <surname>Egger</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis</article-title>
          <source>Journal of Clinical Epidemiology</source>
          <year>2001</year>
          <volume>54</volume>
          <fpage>1046</fpage>
          <lpage>1055</lpage>
          <pub-id pub-id-type="pmid">11576817</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0895-4356(01)00377-8</pub-id>
        </citation>
      </ref>
      <ref id="B37">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuiper</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Lemmen</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Carlsson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Corton</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Safe</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>van der Saag</surname>
              <given-names>PT</given-names>
            </name>
            <name>
              <surname>van der Burg</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gustafsson</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor b</article-title>
          <source>Endocrinology</source>
          <year>1998</year>
          <volume>139</volume>
          <fpage>4252</fpage>
          <lpage>4263</lpage>
          <pub-id pub-id-type="pmid">9751507</pub-id>
          <pub-id pub-id-type="doi">10.1210/en.139.10.4252</pub-id>
        </citation>
      </ref>
      <ref id="B38">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dornstauder</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Jisa</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Unterrieder</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Krenn</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kubelka</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Jungbauer</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Estrogenic activity of two standardized red clover extracts (Menoflavon) intended for large scale use in hormone replacement therapy</article-title>
          <source>J SteroidBiochem Mol Biol</source>
          <year>2001</year>
          <volume>78</volume>
          <fpage>67</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="doi">10.1016/S0960-0760(01)00075-9</pub-id>
        </citation>
      </ref>
      <ref id="B39">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morito</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hirose</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kinjo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hirakawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Okawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nohara</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ogawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Muramatsu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Masamune</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Interaction of phytoestrogens with estrogen receptors alpha and beta</article-title>
          <source>Biol Pharm Bull</source>
          <year>2001</year>
          <volume>24</volume>
          <fpage>351</fpage>
          <lpage>356</lpage>
          <pub-id pub-id-type="pmid">11305594</pub-id>
          <pub-id pub-id-type="doi">10.1248/bpb.24.351</pub-id>
        </citation>
      </ref>
      <ref id="B40">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mendelsohn</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>Nongenomic, ER-mediated activation of endothelial nitric oxide synthase: how does it work? What does it mean?</article-title>
          <source>Circ Res</source>
          <year>2000</year>
          <volume>87</volume>
          <fpage>956</fpage>
          <lpage>960</lpage>
          <pub-id pub-id-type="pmid">11090536</pub-id>
        </citation>
      </ref>
      <ref id="B41">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gruber</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Tschugguel</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Schneeberger</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Huber</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Production and actions of estrogens</article-title>
          <source>N Engl J Med</source>
          <year>2002</year>
          <volume>346</volume>
          <fpage>340</fpage>
          <lpage>352</lpage>
          <pub-id pub-id-type="pmid">11821512</pub-id>
          <pub-id pub-id-type="doi">10.1056/NEJMra000471</pub-id>
        </citation>
      </ref>
      <ref id="B42">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Jayachandran</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>VM</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Douglas PS</surname>
            </name>
          </person-group>
          <article-title>Molecular and cellular mechanisms of estrogen's actions</article-title>
          <source>In Cardiovascular disease and disease in women</source>
          <year>2002</year>
          <edition>2</edition>
          <publisher-name>New York: WB Saunders Company</publisher-name>
          <fpage>207</fpage>
          <lpage>230</lpage>
        </citation>
      </ref>
      <ref id="B43">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Busby</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Jeffcoat</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Bloedon</surname>
              <given-names>LT</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Dix</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Heizer</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Crowell</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Zeisel</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men</article-title>
          <source>Am J Clin Nutr</source>
          <year>2002</year>
          <volume>75</volume>
          <fpage>126</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="pmid">11756070</pub-id>
        </citation>
      </ref>
      <ref id="B44">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>KE</given-names>
            </name>
          </person-group>
          <article-title>Sex and long-term soy diets affect the metabolism and excretion of soy isoflavones in humans</article-title>
          <source>Am J Clin Nutr</source>
          <year>1998</year>
          <volume>suppl 68</volume>
          <fpage>1500</fpage>
          <lpage>1504S</lpage>
        </citation>
      </ref>
      <ref id="B45">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Hendrich</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Neither background diet nor type of soy food affects short-term isoflavone bioavailability in women</article-title>
          <source>J Nutr</source>
          <year>2000</year>
          <volume>130</volume>
          <fpage>798</fpage>
          <lpage>801</lpage>
          <pub-id pub-id-type="pmid">10736332</pub-id>
        </citation>
      </ref>
      <ref id="B46">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sirtori</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Gianazza</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Manzoni</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lovati</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>Role of isoflavones in the cholesterol reduction by soy proteins in the clinic</article-title>
          <source>Am J Clin Nutr</source>
          <year>1997</year>
          <volume>65</volume>
          <fpage>166</fpage>
          <lpage>167</lpage>
          <pub-id pub-id-type="pmid">8988932</pub-id>
        </citation>
      </ref>
      <ref id="B47">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Potter</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Soy protein and cardiovascular disease: the impact of bioactive components in soy</article-title>
          <source>Nutr Rev</source>
          <year>1998</year>
          <volume>56</volume>
          <fpage>231</fpage>
          <lpage>235</lpage>
          <pub-id pub-id-type="pmid">9735676</pub-id>
        </citation>
      </ref>
      <ref id="B48">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Potter</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Overview of proposed mechanisms for the hypocholesterolemic effect of soy</article-title>
          <source>J Nutr</source>
          <year>1995</year>
          <volume>suppl 125</volume>
          <fpage>606</fpage>
          <lpage>611S</lpage>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>